Going flat
- Medical Review: Sameer A. Patel, MD, FACS
Going flat means choosing not to have breast reconstruction after mastectomy—whether you have one or both breasts removed.
Some women decide they want to go flat after talking with their surgeons about breast reconstruction options.
Since 2016, the Going Flat movement, led by patient advocates, has called more attention to going flat as a valid choice after mastectomy. In 2021, a survey of 930 women found that nearly 75% were satisfied with their choice to go flat. Close to 25% also said they didn’t feel supported by their doctors in making that choice.
A woman can choose to go flat immediately after mastectomy or later, after having breast reconstruction. There are many reasons why a woman may choose to go flat. Sometimes, problems with breast reconstructions can lead to a decision to go flat rather than undergo more surgery to correct a reconstruction issue.
Below, you can learn more about going flat—one of many options as you make decisions about breast reconstruction.
Reasons why people decide to go flat
Some people choose to go flat because they don’t want to go through the breast reconstruction process. For others, reconstruction isn't a good option because of other health conditions, out-of-pocket costs, or life circumstances (such as work or caregiving demands).
Some common reasons for deciding not to have breast reconstruction include:
- Faster recovery time: It can take a few weeks to recover from mastectomy alone. With reconstruction, it can take anywhere from 4-8 weeks.
- Wanting to avoid more surgeries: If reconstruction can’t be done at the same time as mastectomy (immediate reconstruction), some people would rather not have another surgery later. Even after reconstruction, more procedures are often needed to produce a good result. Many women decide they don’t want any more surgery.
- Preferring not to have implants: Implant reconstruction is more widely available than tissue reconstruction and has a shorter recovery time. But implants have silicone ingredients, and some women would rather not have artificial materials inside their bodies. Tissue expansion can be another part of implant reconstruction. This process is often needed to stretch the skin to create space for the implant. It can take 6-8 weeks and can be painful for some women.
- Not wanting to go through tissue reconstruction: Tissue reconstruction requires having surgery on another part of the body, such as the belly, thigh, or buttocks. The surgeon removes tissue (called a “flap”) that will be used to create the new breast. This requires more recovery time, and more scarring compared with flat closure.
- Feeling OK about not having breasts: Some women are fine with not having the appearance of breasts, knowing that reconstructed breasts won’t look or feel exactly like what they had before. Others choose to wear a prosthesis (breast form) if there are times when they want the look of having breasts.
- A desire to get back to normal activities more quickly: Women may be caring for children or relatives, working at a job that is physically demanding, or living an active lifestyle they enjoy. They might not want to invest time in the reconstruction process and recovery.
In some cases, reconstruction may not be recommended due to the extent of the cancer.
In other cases, people go flat because they face practical challenges to having reconstruction. Here are some examples:
- Certain health conditions: Conditions such as diabetes, obesity, or heart or lung problems can increase the risk of complications with breast reconstruction.
- Lack of access to plastic surgeons who perform tissue reconstruction: While implant reconstruction is widely available, tissue flap reconstruction is not, because it requires training in microsurgery (joining tiny blood vessels together). If someone doesn't want implants but can’t travel for tissue flap reconstruction, she may decide to go flat.
- Not enough tissue for flap reconstruction: Women with a thin build might not have enough extra tissue in the belly, thighs, or buttocks to create new breasts. They may prefer to go flat rather than use implants.
- Out-of-pocket costs: Health insurance plans are required to pay for breast reconstruction. Plans vary, though, and some people might not be able to afford the out-of-pocket costs of breast reconstruction. Or they might simply decide the cost isn’t worth it.
Every person’s situation is different. You and your care team can discuss the pros and cons of going flat versus having breast reconstruction.
Aesthetic flat closure
After breast tissue is removed during mastectomy, surgeons can perform aesthetic flat closure to remove and/or rearrange excess breast skin to give the chest a smooth, flat appearance. It is also called chest wall reconstruction.
Why get aesthetic flat closure?
Aesthetic flat closure is a surgery technique that creates a smooth, flat chest after mastectomy.
It’s important to ask your surgeon about aesthetic flat closure if you have decided to go flat. Going flat without flat closure can result in bulges of extra skin and/or sunken areas in the chest. Aesthetic flat closure can reduce the risk of these results. Still, results can vary based on individual anatomy.
Flat closure also can be performed if:
- You decide to go flat after having breast implants removed
- In rare situations, if a tissue flap used to create a new breast does not get enough blood supply and dies (flap loss)
Some people would rather not have more surgery to fix these issues, so they choose to have aesthetic flat closure.
Goals and benefits of aesthetic flat closure
The goals of aesthetic flat closure are:
- To remove any extra skin, fat, and other tissue in the chest area
- To rebuild the shape of the chest wall, possibly by rearranging tissue or fat
- To tighten and smooth the skin so that the chest wall appears flat
The benefits of flat closure are:
- It is a simpler surgery than breast reconstruction, with a shorter recovery time.
- Post-operative care is easier than with reconstruction.
- People can return to physical activities more quickly, and they don't have to adjust to having implants or tissue flaps.
- Flat closure achieves the smooth, flat look that most women want if they choose to go flat.
- It avoids leaving bulges of extra skin in the chest area and especially under the arm (often referred to as dog ears).
- It can prevent a concave or scooped-out look after all the breast tissue is removed.
Ask your plastic surgeon what kinds of results you can expect. Results can be different from person to person.
If you want to talk with more than one plastic surgeon before deciding, it is OK to seek a second opinion with a different surgeon.
Nerve repair and aesthetic flat closure
After mastectomy, the chest area will be numb because removing breast tissue also cuts the nerves that provided feeling to the breast. This is true for women who choose breast reconstruction or aesthetic flat closure.
However, some people may be able to have nerve repair to restore some feeling to the chest area.
For example, a nerve repair procedure called Resensation uses donated, sterilized human nerve tissue, called a graft, to connect cut nerves to nerve endings in the chest area. Over time, the nerve ends can grow and reconnect through the graft, and some feeling may return.
This nerve repair procedure is more likely to work well if flat closure happens immediately after mastectomy. To learn more, visit breast reconstruction.
Timing of aesthetic flat closure
If you’ve decided to go flat after mastectomy, aesthetic flat closure is usually done at the same time. However, there may be good reasons to have the procedure later (delayed flat closure). For example:
- You are not 100% certain you want to go flat. Some surgeons feel that having extra skin in place is helpful if you decide later that you want reconstruction. But if you make up your mind to go flat, ask for aesthetic flat closure. And if you do go flat right away and change your mind later, there are still reconstruction options.
- Your breast surgeon doesn’t have experience with flat closure. Your breast cancer surgeon may not have the training or the experience to give you the results you want. If they can’t bring in a plastic surgeon to help, you may need to go ahead with mastectomy and have aesthetic flat closure later.
In this case, delayed flat closure allows time to find a plastic surgeon with experience in this surgery. If you have extra skin or sunken areas in your chest after the mastectomy, these can be repaired at that time.
Other things to consider with timing:
- Even if aesthetic flat closure is done right away, you may need a second procedure later to correct issues such as dents or to revise scarring.
- If radiation therapy is part of your treatment plan after aesthetic flat closure, it’s important to know that radiation can cause the skin to become red, tender, and tight. But once the area heals, plastic surgeons can use secondary reconstruction procedures such as fat grafting to smooth out any uneven areas.
If you are having flat closure after explant surgery (removal of breast implants), it would usually be done at the same time as explant surgery, by the same plastic surgeon.
Who should perform aesthetic flat closure?
Some breast surgeons who treat breast cancer can perform aesthetic flat closure. Ask your breast surgeon if they are trained in how to do the procedure.
Plastic surgeons who specialize in breast reconstruction also can perform aesthetic flat closure. Your breast cancer surgeon may decide to collaborate with a plastic surgeon who can complete the flat closure after mastectomy. If not, it’s OK to ask for a plastic surgeon to be involved. In some people, achieving a smooth, flat result can be much more challenging, for several reasons:
- Larger breast size
- Higher Body Mass Index (BMI)
- More sagging in the breasts (this is called ptosis)
- More skin under the arms
- Having cancer that is located at the base of the breast, close to the chest wall
- Already having, or needing to have, radiation therapy to the area
A plastic surgeon is more likely to have experience dealing with these challenges.
Every person’s body is different. Share your concerns with your care team and ask them what makes sense for your situation.
If you have decided you want aesthetic flat closure after a past reconstruction, or after prophylactic mastectomy (breast removal to reduce cancer risk), ask the plastic surgeon performing your surgery if they have experience with aesthetic flat closure.
You might need to do your own research to find a surgeon experienced with aesthetic flat closure. The flat advocacy group Not Putting on a Shirt has a flat-friendly surgeons directory that may be helpful. However, it doesn’t include every breast and plastic surgeon who offers flat closure.
Health insurance coverage for aesthetic flat closure
The Women’s Health and Cancer Rights Act (WHCRA) of 1998 requires health insurance plans to cover breast reconstruction after mastectomy. This includes any surgeries needed to bring the breasts into balance, as well as to treat any complications.
In fall 2024, the Centers for Medicare and Medicaid Services (CMS) stated that health plans are also required to provide coverage for chest wall reconstruction with aesthetic flat closure. Some states, including New York and Indiana, have insurance laws requiring insurance companies to cover it.
Every health insurance plan is different, though, so check with yours to make sure flat closure is covered as a reconstruction procedure.
For more about aesthetic flat closure, read Aesthetic flat closure: An option after breast cancer surgery.
Communicating with your surgical team
While there are many breast surgeons who perform flat closure, plastic surgeons generally have more experience with this surgery.
Some surgeons strongly encourage breast reconstruction after mastectomy. They might not mention going flat as an option. They also might dismiss the idea if you bring it up.
Some women who asked to go flat after mastectomy have reported that their surgeons left extra skin behind, just in case they eventually wanted reconstruction. Or, their surgeons simply did not have the experience and training to achieve a smooth, flat result. Advocates call this flat denial.
It’s important that you feel heard when you’re letting your breast surgeon know your wishes. You might want to:
- Search online for “flat closure results” and bring images that show the results you want.
- Ask the surgeon how often they perform aesthetic flat closure, and if they have completed training in how to do the procedure.
- Ask to see photos of their flat closure work.
- Ask if you can speak with any of their former patients who had flat closure.
- Request that your breast surgeon partner with a plastic surgeon experienced in flat closure.
If you are feeling pressured to have reconstruction even after letting your surgeon know you want to go flat, seek a second opinion with another breast surgeon or a plastic surgeon. It’s important to be able to go into surgery feeling confident that your surgeon knows what you want.
If you’re having flat closure after a past reconstruction, whether with implants or tissue flaps, you’ll already be working with a plastic surgeon. You can ask how much experience they have with aesthetic flat closure.
Not Putting on a Shirt offers support and guidance on how to advocate for yourself if you have decided to go flat.
Living flat
Mastectomy is a major change to the body that can impact how you feel about yourself.
Whether someone chooses breast reconstruction or decides to go flat, the chest area will feel and look different than it did with natural breasts. That can be a big adjustment, so give yourself time to get used to your post-surgery body.
Living flat—whether you’re fully flat or flat on one side—can be different for everyone:
- Some people feel comfortable going flat all the time.
- Others decide to use a breast prosthesis, an artificial breast form that can be worn inside a bra or on the chest to create the appearance of breasts. There are many different types available, ranging from lightweight pads to silicone breast forms. A breast prosthesis is something you can wear whenever you want—whether it’s all the time or just once in a while.
Dressing flat
Dressing with a flat chest may feel different at first. Some people find it helpful to choose tops that camouflage the chest, including:
- Draped or ruffled tops
- Dark colors and patterned fabrics
- T-shirts layered with a jacket, sweater, scarf, or shawl
- Athletic tops or swim tops with some built-in padding
The websites of advocacy groups such as Not Putting on a Shirt and Flat Closure Now feature some great ideas for dressing with a flat chest. You can also find ideas by searching on social media. You’ll notice that some women even choose decorative tattoos to make a statement with their flat chests.
I certainly catch people glancing at the flatness of my chest, and that is fine, because I am not only comfortable in my skin, but I am cancer-free. Do I wear loose fitting clothing? Not at all. I want people to see me as a woman who has been through cancer and have chosen to live unapologetically flat.
Sex and intimacy after going flat
Sexuality and intimacy can feel different after going flat, especially if your natural breasts were a source of pleasure. After mastectomy, there will be less sensation in the chest than before.
The same is true for women who choose reconstruction with breast implants or tissue flaps. That’s because removing breast tissue also cuts the nerves that provide feeling to the chest. Whether you have a romantic partner now or plan to date in the future, open and honest communication will help you figure out what works for you.
As author Catherine Guthrie wrote, “Post-cancer sex will never be the same as pre-cancer sex because YOU are not the same. My partner and I struggled to regain intimacy after my double mastectomy. But it wasn’t because I’d lost my breasts; it was because I’d lost my confidence. Once she made it clear that body confidence was much sexier to her than breasts, I realized I’d been fixated on what I lost instead of what I had—a beautiful, vibrant, healthy body!”
Whatever your concerns are after going flat, give yourself time to experiment and figure out what works for you.
Stay connected
Sign up to receive emotional support, medical insight, personal stories, and more, delivered to your inbox weekly.
- 3-dimensional radiation therapy
- 4-hydroxytamoxifen
- ablation
- abnormal
- Abraxane
- absolute risk
- AC regimen
- AC-T regimen
- AC-T-T regimen
- AC-Taxol regimen
- AC-TH regimen
- accelerated partial-breast irradiation
- action study
- acupoint
- acupressure
- acupuncture
- acupuncture needle
- acupuncture point
- acupuncture point injection
- acupuncturist
- acustimulation
- acute
- acute pain
- adenocarcinoma
- adenopathy
- adenosis
- adjunct agent
- adjunct therapy
- adjunctive therapy
- adjuvant therapy
- advance directive
- advanced practice nurse
- adverse effect
- aerobic exercise
- agent study
- aggravating factor
- aggressive
- AJCC staging system
- Alkeran
- alkylating agent
- Allegra
- allopathic medicine
- alopecia
- amifostine
- aminoglutethimide
- amitriptyline
- anabolic steroid
- analgesic
- anaplastic
- anastrozole
- ancillary test
- anemia
- anesthesia
- anesthesiologist
- angiogenesis
- angiogenesis inhibitor
- antagonist
- anthracycline
- anti-anxiety medicine
- anti-idiotype vaccine
- anti-inflammatory
- antibody-dependent cellular cytotoxicity
- antibody therapy
- anticachexia
- anticancer antibiotic
- anticancer therapy
- anticonvulsant
- antidepressant
- antiemetic
- antiestrogen
- antifolate
- antigen-presenting cell vaccine
- antihormone therapy
- antimetabolite
- antimitotic agent
- antineoplastic
- antitumor
- anxiety
- anxiolytic
- Anzemet
- APN
- apocrine gland
- apoptosis
- aprepitant
- areola
- Aromasin
- aromatase inhibitor
- aromatherapy
- arthralgia
- ascites
- aspirate
- aspiration
- assay
- asthenia
- asymptomatic
- atypia
- atypical ductal hyperplasia
- atypical hyperplasia
- atypical lobular hyperplasia
- avoidance
- axillary lymph node
- axillary lymph node dissection
- BAK gel
- balloon catheter radiation
- baseline
- behavior modification
- best practice
- BI-RADS
- Biafine cream
- bias
- bilateral
- bilateral breast cancer
- bilateral prophylactic mastectomy
- bilateral salpingo-oophorectomy
- biofeedback
- biologic
- biopsy
- biopsy specimen
- biotherapy
- bisphosphonate
- bisphosphonate-associated osteonecrosis
- blinded study
- blood-brain barrier
- blood-brain barrier disruption
- blood cell count
- blood chemistry study
- board certified oncology pharmacy specialist
- body image
- body mass index
- bolus dose
- bone density
- bone metastasis
- bone mineral density scan
- bone scan
- bone-seeking radioisotope
- brachytherapy
- brain metastasis
- BRCA1
- BRCA2
- BRCAPro
- breast carcinoma in situ
- breast-conserving surgery
- breast density
- breast duct
- breast duct endoscopy
- breast lobe
- breast lobule
- breast reconstruction
- breast self-exam
- Brief Pain Inventory
- cachexia
- CAF regimen
- calcification
- cancer vaccine
- candidiasis
- capecitabine
- carboplatin
- carcinogen
- carcinoma
- carcinoma in situ
- carcinomatous meningitis
- carcinosis
- carcinostatic
- cardiotoxicity
- caregiver
- carmustine
- case-control study
- case report
- case series
- CAT scan
- CBC
- cell
- cell-cycle regulation
- cell proliferation
- central nervous system
- central nervous system metastasis
- central nervous system prophylaxis
- central venous access catheter
- cetuximab
- cevimeline
- chaplain
- charged-particle radiation therapy
- chemoembolization
- chemoimmunotherapy
- chemoprevention
- chemoprevention study
- chemoprotective
- chemoradiation
- chemosensitivity
- chemosensitivity assay
- chemosensitizer
- chemotherapeutic agent
- chemotherapy
- chest wall
- chest X-ray
- Chinese meridian theory
- chronic
- chronic pain
- cisplatin
- Claus model
- clergy
- clinical
- clinical breast exam
- clinical practice guidelines
- clinical researcher
- clinical resistance
- clinical series
- clinical stage
- clinical staging
- clinical study
- clinical trial
- clinician
- clodronate
- CMF regimen
- cognition
- cognitive behavior therapy
- cognitive therapy
- cohort
- cohort study
- coinsurance
- combination chemotherapy
- comedo carcinoma
- comfort care
- Coming Out
- Community Advisory Board
- comorbidity
- compassionate use trial
- complementary and alternative medicine
- complementary medicine
- complete metastasectomy
- complete remission
- complete response
- complex decongestive therapy
- compliance
- complication
- compression garment
- computed tomography scan
- concomitant
- concurrent therapy
- condition
- consolidation therapy
- constitutional acupuncture
- continuum of care
- contract research organization
- contraindication
- contralateral
- contrast material
- control group
- controlled clinical trial
- controlled study
- conventional medicine
- conventional therapy
- copayments
- cope
- coping skills
- core biopsy
- core needle biopsy
- corticosteroid
- counseling
- COX inhibitor
- cryoablation
- cryopreservation
- cryosurgery
- CT scan
- cultural competency
- cumulative dose
- cumulative exposure
- cure
- cutaneous
- cutaneous breast cancer
- cyclophosphamide
- cyclosporine
- CYP2D6 inhibitor
- cystosarcoma phyllodes
- cytopenia
- cytotoxic
- cytotoxic chemotherapy
- Cytoxan
- Data and Safety Monitoring Board
- DCIS
- de novo
- debulking
- deductible
- definitive surgery
- definitive treatment
- dehydration
- denosumab
- depression
- diagnosis
- diagnostic mammogram
- diagnostic procedure
- diagnostic technique
- diagnostic trial
- diameter
- diarrhea
- diaziquone
- DIEP flap
- dietary counseling
- dietary supplement
- dietitian
- differentiation
- diffuse
- digital mammography
- diphenhydramine
- discharge
- disease progression
- disease-specific survival rate
- distant cancer
- distant metastasis
- Distant recurrence
- distress
- DNR order
- docetaxel
- dolasetron
- dose
- dose-dense chemotherapy
- dose-dependent
- dose-limiting
- dose-rate
- double-blinded
- doxorubicin
- drain
- dronabinol
- droperidol
- drug interaction
- drug resistance
- drug therapy
- drug tolerance
- duct
- ductal carcinoma
- ductal carcinoma in situ
- ductal lavage
- duloxetine
- durable power of attorney
- dysfunction
- dysgeusia
- dyspepsia
- dyspnea
- early menopause
- early-stage breast cancer
- edema
- EEG biofeedback
- efficacy
- Eklund displacement views
- electroacupuncture
- electron beam
- eligibility criteria
- Ellence
- emesis
- emetic
- endocrine
- endocrine therapy
- endpoint
- energy healing
- enteral nutrition
- epidemiology
- epirubicin
- ER+
- ER-
- ER
- ER-PR-HER2/neu-
- eribulin mesylate
- erythema
- estradiol
- estrogen
- estrogen blocker
- estrogen receptor
- estrogen receptor-negative
- estrogen receptor-positive
- estrogen receptor test
- estrogen replacement therapy
- etanidazole
- etidronate
- everolimus
- Evista
- excision
- excisional biopsy
- exemestane
- expanded access trial
- experimental
- extranodal
- false-negative test result
- false-positive test result
- familial cancer
- family medical history
- Faslodex
- fast-neutron beam radiation
- fatigue
- FDA
- febrile neutropenia
- FEC regimen
- Femara
- fertility
- fexofenadine
- fibroadenoma
- fibrocystic breast changes
- fiducial marker
- film mammography
- fine-needle aspiration biopsy
- first-degree relative
- first-line therapy
- five-year survival rate
- fluorouracil
- fluoxetine
- FNA biopsy
- focal
- Food and Drug Administration
- Fosamax
- fractionation
- fulvestrant
- functional magnetic resonance imaging
- gadolinium
- Gail model
- gallium scan
- gamma irradiation
- Gamma Knife therapy
- gamma ray
- Gelclair
- gemcitabine
- gene
- gene expression profile
- gene therapy
- general anesthesia
- generalized anxiety disorder
- generic
- genetic
- genetic counseling
- genetic marker
- genetic marker of susceptibility
- genetic predisposition
- genetic profile
- genetic susceptibility
- genetic testing
- genetic testing
- genetics
- genome
- genome-wide association study
- genomic profile
- genomic test
- genomics
- gland
- Good Clinical Practice
- goserelin
- grade
- grading
- granisetron
- gross description
- Halaven
- hazard ratio
- healing touch
- Health Insurance Portability and Accountability Act
- healthcare provider
- healthcare proxy
- healthy control
- helical computed tomography
- HER2/neu
- Herceptin
- hereditary
- hereditary mutation
- heteronormative
- high-dose chemotherapy
- high-dose radiation
- high-energy proton therapy
- high grade
- high-risk cancer
- HIPPA
- histologic examination
- histology
- historic cohort study
- historical control subject
- homeopathic medicine
- hormonal therapy
- hormone
- hormone receptor
- hormone receptor test
- hormone replacement therapy
- hormone responsive
- hormone therapy
- hospice
- hot flash
- human epidermal growth factor receptor 2
- human participant protection regulations
- hydroxydaunorubicin
- hyperalimentation
- hypercalcemia
- hyperfractionated radiation therapy
- hyperfractionation
- hyperplasia
- hypersensitivity
- hypofractionated radiation therapy
- hypofractionation
- hypoxia
- ibandronate
- ibuprofen
- idiopathic
- image-guided radiation therapy
- imaging
- imaging procedure
- immune adjuvant
- immune function
- immune response
- immune system
- immune system tolerance
- immunization
- immunoassay
- immunocompromised
- immunodeficiency
- immunohistochemistry
- immunology
- immunomodulation
- immunosuppression
- immunotherapy
- implant
- implant displacement views
- implant radiation therapy
- implantable pump
- in network
- in situ
- incidence
- incision
- incisional biopsy
- indication
- indolent
- induction therapy
- infection
- infertile
- infertility
- infiltrating breast cancer
- infiltrating ductal carcinoma
- inflammation
- inflammatory breast cancer
- informed consent
- infusion
- ingestion
- inherited
- iniparib
- injection
- inoperable
- insomnia
- Institutional Review Board
- intensification therapy
- intensity-modulated radiation therapy
- interfering thought
- internal mammary lymph nodes
- internal radiation therapy
- International Unit
- internist
- interstitial radiation therapy
- intervention
- intervention group
- intra-arterial
- intracarotid infusion
- intradermal
- intraductal breast papilloma
- intraductal carcinoma
- intrahepatic
- intrahepatic infusion
- intramuscular
- intramuscular injection
- intraoperative radiation therapy
- intraoperative ultrasound
- intratumoral
- intravasation
- intravenous
- intravenous infusion
- intravenous injection
- intrusive thought
- intrusive thoughts
- invasive breast cancer
- invasive cancer
- invasive procedure
- investigational
- investigator
- ionizing radiation
- ipsilateral
- IRB
- irradiated
- irradiation
- irreversible toxicity
- ixabepilone
- joint pain
- Karnofsky Performance Status
- laboratory test
- lapatinib
- laser
- laser surgery
- laser therapy
- lassitude
- late effects
- late-stage cancer
- latent
- laxative
- LEEP
- legal aid organization
- lesion
- lethargy
- letrozole
- leukopenia
- levels of evidence
- Lexapro
- libido
- lidocaine
- ligation
- linac
- linear accelerator
- lipoma
- lisofylline
- liver metastasis
- liver scan
- living will
- lobaplatin
- lobe
- lobectomy
- lobular carcinoma
- lobular carcinoma in situ
- lobule
- local anesthesia
- local cancer
- local therapy
- localization
- localized
- locally advanced cancer
- locally recurrent cancer
- lomustine
- loop electrosurgical excision procedure
- loop excision
- lorazepam
- low grade
- lubricant
- lumbar puncture
- lumpectomy
- lung metastasis
- luteinizing hormone-releasing hormone agonist
- lymph
- lymph gland
- lymph node
- lymph node dissection
- lymph node drainage
- lymph node mapping
- lymph vessel
- lymphadenectomy
- lymphadenopathy
- lymphangiogram
- lymphangiography
- lymphatic basin
- lymphatic fluid
- lymphatic mapping
- lymphatic system
- lymphatic vessel
- lymphedema
- lymphography
- lymphoscintigraphy
- Lyrica
- lytic lesion
- macrocalcification
- magnetic resonance imaging
- magnetic resonance perfusion imaging
- magnetic resonance spectroscopic imaging
- mainstream medicine
- maintenance therapy
- male breast cancer
- malignancy
- malignant
- malignant pleural effusion
- malnutrition
- mammary
- mammary dysplasia
- mammary gland
- mammogram
- mammography
- MammoSite
- Mammotome
- mantle field
- MAO inhibitor
- margin
- marker
- mass
- massage therapy
- mastectomy
- mastitis
- maternal
- maximum tolerated dose
- mean survival time
- measurable disease
- medial supraclavicular lymph node
- median
- median survival time
- Medicaid
- medical castration
- medical device
- medical nutrition therapy
- medical oncologist
- Medicare
- medicine
- medullary breast carcinoma
- mega-voltage linear accelerator
- megestrol
- melphalan
- meningeal metastasis
- menopause
- menorrhagia
- menstrual cycle
- menstrual period
- menstruation
- mental health
- mental health counselor
- meridian
- mesna
- meta-analysis
- metallic
- metastasectomy
- metastasis
- metastasize
- metastatic
- methotrexate
- metoclopramide
- metronomic therapy
- microcalcification
- micrometastasis
- microscopic
- milk duct
- mind/body exercise
- mindfulness relaxation
- Miraluma test
- mitigate
- modified radical mastectomy
- molecular marker
- molecular medicine
- molecular risk assessment
- molecularly targeted therapy
- monoamine oxidase inhibitor
- monoclonal antibody
- morbidity
- mortality
- MRI
- MRSI
- MTD
- mTOR
- mucositis
- multicenter study
- multicentric breast cancer
- multidisciplinary
- multidisciplinary opinion
- multidrug resistance
- multidrug resistance inhibition
- multifocal breast cancer
- music therapy
- mutation
- mutation carrier
- myalgia
- myelosuppression
- nanoparticle paclitaxel
- narcotic
- National Cancer Institute
- National Center for Complementary and Alternative Medicine
- National Institutes of Health
- natural history study
- naturopathy
- nausea
- NCCAM
- NCI
- NCI clinical trials cooperative group
- needle biopsy
- needle localization
- needle-localized biopsy
- negative axillary lymph node
- negative test result
- neoadjuvant therapy
- neoplasm
- nerve
- nerve block
- neurocognitive
- neurologic
- neuropathy
- neurotoxicity
- neurotoxin
- neutropenia
- NIH
- nipple
- nipple discharge
- nitrosourea
- NMRI
- node-negative
- node-positive
- nodule
- nonblinded
- nonconsecutive case series
- noninvasive
- nonmalignant
- nonmetastatic
- nonprescription
- nonrandomized clinical trial
- nonsteroidal anti-inflammatory drug
- nonsteroidal aromatase inhibitor
- nontoxic
- normal range
- normative
- NP
- NPO
- NSAID
- nuclear grade
- nuclear magnetic resonance imaging
- nuclear medicine scan
- nurse
- nurse practitioner
- nutrition
- nutrition therapy
- nutritional counseling
- nutritional status
- nutritional supplement
- nutritionist
- obese
- objective improvement
- objective response
- observation
- observational study
- obstruction
- off-label
- olaparib
- oncologist
- oncology
- oncology nurse
- oncology pharmacy specialist
- oncolysis
- ondansetron
- onset of action
- oophorectomy
- open biopsy
- open label study
- open resection
- operable
- opiate
- opioid
- opportunistic infection
- oral
- organ
- orthodox medicine
- osteolytic
- osteonecrosis of the jaw
- osteopenia
- osteoporosis
- OTC
- out of network
- outcome
- outpatient
- ovarian
- ovarian ablation
- ovarian cancer
- ovarian suppression
- ovary
- over-the-counter
- overall survival rate
- overdose
- overexpress
- overweight
- ovulation
- PA
- paclitaxel
- paclitaxel albumin-stabilized nanoparticle formulation
- paclitaxel-loaded polymeric micelle
- Paget disease of the nipple
- pain threshold
- palliation
- palliative care
- palliative therapy
- palmar-plantar erythrodysesthesia
- palonosetron hydrochloride
- palpable disease
- palpation
- palpitation
- pamidronate
- panic
- papillary tumor
- Paraplatin
- parenteral nutrition
- paroxetine hydrochloride
- PARP
- PARP inhibitor
- partial-breast irradiation
- partial mastectomy
- partial oophorectomy
- partial remission or partial response
- pastoral counselor
- paternal
- pathologic fracture
- pathological stage
- pathological staging
- pathologist
- pathology report
- patient advocate
- Paxil
- peau d'orange
- pedigree
- peer-review process
- peer-reviewed scientific journal
- perfusion magnetic resonance imaging
- perimenopausal
- periodic neutropenia
- perioperative
- peripheral neuropathy
- peripheral venous catheter
- personal health record
- personal medical history
- personalized medicine
- Pertuzumab
- PET scan
- pharmacist
- phase I/II trial
- phase I trial
- phase II/III trial
- phase II trial
- phase III trial
- phase IV trial
- phlebotomy
- photon beam radiation therapy
- phyllodes tumor
- physical examination
- physical therapist
- physical therapy
- physician
- physician assistant
- physiologic
- PI3 kinase inhibitor
- pilocarpine
- pilot study
- placebo
- placebo-controlled
- plastic surgeon
- plastic surgery
- population study
- positive axillary lymph node
- positive test result
- positron emission tomography scan
- post-traumatic stress disorder
- postmenopausal
- postoperative
- postremission therapy
- potentiation
- power of attorney
- PR
- PR+
- PR-
- practitioner
- preauthorization
- precancerous
- preclinical study
- predictive factor
- pregabalin
- premalignant
- premature menopause
- premenopausal
- premium
- prescription
- prevention
- preventive
- preventive mastectomy
- primary care
- primary care doctor
- primary endpoint
- primary therapy
- primary treatment
- primary tumor
- Principal investigator
- prochlorperazine
- progesterone
- progesterone receptor
- progesterone receptor-negative
- progesterone receptor-positive
- progesterone receptor test
- progestin
- prognosis
- prognostic factor
- progression
- progression-free survival
- progressive disease
- Prolia
- proliferative index
- promegapoietin
- prophylactic
- prophylactic mastectomy
- prophylactic oophorectomy
- prophylactic surgery
- prophylaxis
- prospective
- prospective cohort study
- prosthesis
- protective factor
- protein
- protein-bound paclitaxel
- protein expression
- protein expression profile
- protocol
- proton
- proton magnetic resonance spectroscopic imaging
- pruritus
- psychiatrist
- psychological
- psychologist
- psychosocial
- psychotherapy
- PTSD
- pump
- punch biopsy
- qi
- qigong
- quadrantectomy
- quality assurance
- quality of life
- radiation
- radiation brachytherapy
- radiation dermatitis
- radiation fibrosis
- radiation necrosis
- radiation nurse
- radiation oncologist
- radiation physicist
- radiation surgery
- radiation therapist
- radiation therapy
- radical lymph node dissection
- radical mastectomy
- radioactive
- radioactive drug
- radioactive seed
- radioisotope
- radiologic exam
- radiologist
- radiology
- radionuclide
- radionuclide scanning
- radiopharmaceutical
- radiosensitization
- radiosensitizer
- radiosurgery
- radiotherapy
- raloxifene
- raloxifene hydrochloride
- randomization
- randomized clinical trial
- receptor
- RECIST
- reconstructive surgeon
- reconstructive surgery
- recreational therapy
- recurrence
- recurrent cancer
- referral
- reflexology
- refractory
- refractory cancer
- regimen
- regional
- regional anesthesia
- regional cancer
- regional chemotherapy
- regional lymph node
- regional lymph node dissection
- registered dietician
- regression
- rehabilitation
- rehabilitation specialist
- relapse
- relative survival rate
- relaxation technique
- remission
- remission induction therapy
- remote brachytherapy
- research nurse
- research study
- resectable
- resected
- resection
- residual disease
- resistant cancer
- resorption
- respite care
- response rate
- retrospective cohort study
- retrospective study
- risk factor
- Rubex
- salpingo-oophorectomy
- salvage therapy
- samarium 153
- sargramostim
- scalpel
- scan
- scanner
- scintigraphy
- scintimammography
- sclerosing adenosis
- screening
- screening mammogram
- second-line therapy
- second-look surgery
- second primary cancer
- secondary cancer
- secrete
- sedative
- segmental mastectomy
- selection bias
- selective estrogen receptor modulator
- selective serotonin reuptake inhibitor
- sentinel lymph node
- sentinel lymph node biopsy
- sentinel lymph node mapping
- sepsis
- sequential AC/Taxol-Trastuzumab regimen
- sequential treatment
- SERM
- sertraline
- Serzone
- sestamibi breast imaging
- sexuality
- sibling
- side effect
- silicone
- simple mastectomy
- simulation
- Single-agent therapy
- sleep disorder
- social service
- social support
- social worker
- sodium thiosulfate
- soft tissue
- solid tumor
- somatic
- somatic mutation
- sorafenib
- specialist
- specificity
- spiculated mass
- spinal anesthesia
- spinal block
- spiral CT scan
- spirituality
- sporadic cancer
- SSRI
- stable disease
- stage
- stage 0 breast carcinoma in situ
- stage 0 disease
- stage I breast cancer
- stage IA breast cancer
- stage IB breast cancer
- stage II breast cancer
- stage II breast cancer
- stage IIA breast cancer
- stage IIB breast cancer
- stage III breast cancer
- stage III lymphedema
- stage IIIA breast cancer
- stage IIIB breast cancer
- stage IIIC breast cancer
- stage IV breast cancer
- staging
- stamina
- standard of care
- standard therapy
- statistically significant
- stent
- stereotactic biopsy
- stereotactic radiosurgery
- sterile
- sternum
- steroid
- stress
- strontium
- study agent
- subcutaneous
- subcutaneous port
- subjective improvement
- subset analysis
- supplemental nutrition
- supplementation
- support group
- supportive care
- supraclavicular lymph node
- surgeon
- surgery
- surgical biopsy
- surgical menopause
- surgical oncologist
- survival rate
- symptom
- symptom management
- symptomatic
- synergistic
- synthetic
- syringe
- systemic
- systemic chemotherapy
- systemic disease
- systemic therapy
- TAC regimen
- tai chi
- tailored intervention
- talk therapy
- tamoxifen
- targeted therapy
- taxane
- Taxol
- Taxotere
- Tc 99m sulfur colloid
- technician
- terminal disease
- therapeutic
- therapeutic touch
- therapy
- thermography
- thiethylperazine
- thiotepa
- third-line therapy
- thrush
- time to progression
- tinnitus
- tissue
- tissue flap reconstruction
- TNM staging system
- tomography
- tomotherapy
- topical
- topical chemotherapy
- topoisomerase inhibitor
- total estrogen blockade
- total mastectomy
- total nodal irradiation
- total parenteral nutrition
- toxic
- toxicity
- tracer
- traditional acupuncture
- tranquilizer
- transdermal
- transfusion
- transitional care
- translational research
- trastuzumab
- trauma
- treatment field
- trigger
- trigger point acupuncture
- triple-negative breast cancer
- tumescent mastectomy
- tumor
- tumor antigen vaccine
- tumor board review
- tumor burden
- tumor debulking
- tumor load
- tumor marker
- tumor volume
- Tykerb
- ulcer
- ulceration
- ultrasound-guided biopsy
- ultrasound/ultrasonography
- ultraviolet radiation therapy
- uncontrolled study
- undifferentiated
- unilateral
- unilateral salpingo-oophorectomy
- unresectable
- unresected
- upstaging
- urticaria
- VACB
- vaccine therapy
- vacuum-assisted biopsy or vacuum-assisted core biopsy
- Valium
- vancomycin
- vandetanib
- vascular endothelial growth factor-antisense oligonucleotide
- vascular endothelial growth factor receptor tyrosine kinase inhibitor
- vein
- Velban
- venipuncture
- venous sampling
- Versed
- vertebroplasty
- vinorelbine
- vital
- vomit
- watchful waiting
- wedge resection
- Wellcovorin
- Western medicine
- WGA study
- white blood cell
- whole cell vaccine
- whole genome association study
- wide local excision
- wire localization
- wound
- X-ray therapy
- Xanax
- Xeloda
- xerostomia
- Xgeva
- yoga
- ziconotide
- Zinecard
- Zofran
- zoledronic acid
- Zoloft
- Zometa
Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer. To fulfill its mission of providing trusted information and a community of support to those impacted by the disease, Living Beyond Breast Cancer offers on-demand emotional, practical, and evidence-based content. For over 30 years, the organization has remained committed to creating a culture of acceptance — where sharing the diversity of the lived experience of breast cancer fosters self-advocacy and hope. For more information, learn more about our programs and services.